Journal of Biological Chemistry · 1995 · 16 citations · 47 references
Life SciencesGeneticsMolecular BiologyGene ExpressionMolecular OncologyTranscriptional RegulationGene Expression RegulationPromoter RecognitionPromoter RegulationTranscription In EukaryotesTranscription Start SitesCell Type-specific Enhancer ActivityCell-type Specific TranscriptionCell-type-specific EnhancersEnhancer Activity AssaysMammalian PromotersPromoter-reporter ConstructsReporter GenesTransient Gene Expression
The expression of multidrug resistance/P-glycoprotein genes mdr1b(mdr1) and mdr1a(mdr3) is elevated during hepatocarcinogenesis. To investigate the regulation of mdr1b gene expression, we used transient transfection expression assays of reporter constructs containing various 5'-mdr1b flanking sequences in hepatoma and non-hepatoma cells. We found that nucleotides -233 to -116 preferentially enhanced the expression of reporter gene in mouse hepatoma cell lines in an orientation- and promoter context-independent manner. DNase I footprinting using nuclear extracts prepared from hepatoma and non-hepatoma cells identified four protein binding sites at nucleotides -205 to -186 (site A), -181 to -164 (site B), -153 to -135 (site C), and -128 to -120 (site D). Further analyses revealed that, while site B alone played a major part for the enhancer function, sites A and B combined conferred full enhancer activity. Site-directed mutagenesis results also supported these results. Gel retardation experiments using oligonucleotide competitors revealed that the site B contains a dominant binding protein. This is the first report demonstrating a cell type-specific enhancer in the mdr locus. The role of this enhancer in the activation of mdr1b gene during hepatocarcinogenesis is discussed.
47
Definition of a consensus binding site for p53
Wafik S. El‐Deiry, Scott E. Kern, Jennifer A. Pietenpol et al. · Nature Genetics · 1992 · 2K citations